Isradipine
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433917This classification denotes a calcium channel blocker with the molecular formula C19H21N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YO1UK1S598, chemically known as 2,1,3-benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv. but generally known as isradipine, which bears US NIH Compound Identifier 3784. European Medicines Agency schedules Isradipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08346MIG. The term ISRADIPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules isradipine in its Anatomical Therapeutic Chemical (ATC) Classification. ISRADIPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isradipine under HS 29349990 and SITC 51579. As of Q4 2014, ISRADIPINE remains the US FDA Preferred Term for this commodity. Isradipine bears US NLM identifiers UMLS ID C0071304 and NCI Concept Code C47577. SMILES: O(C(=O)C1=C(NC(=C(C1c1c2nonc2ccc1)C(=O)OC)C)C)C(C)C.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.